Skip Navigation


JAC Advance Access originally published online on March 12, 2009
Journal of Antimicrobial Chemotherapy 2009 63(5):849-861; doi:10.1093/jac/dkp065
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
63/5/849    most recent
dkp065v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gould, F. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gould, F. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Reviews

Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

F. Kate Gould1,*, Richard Brindle2, Paul R. Chadwick3, Adam P. Fraise4, Simon Hill5, Dilip Nathwani6, Geoff L. Ridgway7, Michael J. Spry1, Rod E. Warren8 on behalf of the MRSA Working Party of the British Society for Antimicrobial Chemotherapy

1 Department of Microbiology, Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne NE7 7DN, UK 2 Department of Microbiology, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK 3 Department of Microbiology, Salford Royal Hospital, Salford M6 8HD, UK 4 Department of Medical Microbiology, City Hospital NHS Trust, Dudley Road, Birmingham B18 7QH, UK 5 Department of Microbiology, Poole Hospital, Longfleet Road, Poole BH15 2JB, UK 6 Infection Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK 7 Department of Health, Wellington House, 133-135 Waterloo Road, London SE1 8UG, UK 8 Department of Microbiology, Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury SY3 8XQ, UK

* Corresponding author. Tel: +44-191-223-1248; Fax: +44-191-223-1224; E-mail: kate.gould{at}nuth.nhs.uk

These evidence-based guidelines are an updated version of those published in 2006. They have been produced after a literature review of the treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA). The guidelines aim to complement those recently published for the antibiotic treatment of common and emerging community-onset MRSA infections in the UK. The guidelines have reviewed and updated, where appropriate, previous recommendations, taking into account any changes in the UK epidemiology of MRSA, ongoing national surveillance data and the value of new antistaphylococcal agents licensed for use in UK practice. Emerging therapies that have not been licensed for UK use are not reviewed, but their future potential role has been mentioned where deemed appropriate. Recommendations are given for the treatment of common infections caused by MRSA, elimination of MRSA from carriage sites and prophylaxis of surgical site infection.

Keywords: update , evidence-based guidelines , meticillin , new antistaphylococcal agents , UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
J. R. Samuel and F. K. Gould
Prosthetic joint infections: single versus combination therapy
J. Antimicrob. Chemother., November 12, 2009; (2009) dkp398v1.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Brindle and on behalf of Wessex Microbiologists
Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia?
J. Antimicrob. Chemother., November 1, 2009; 64(5): 1111 - 1113.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.